All updated as on -
With a predicted CAGR of 13.5% from 2024–2031, the worldwide coagulation testing market will increase from an initial valuation of $3.14B in 2023 to $8.18B in 2031. When fibrinogen, a soluble plasma protein, transforms into fibrin, a solid gel, the blood's physical characteristics alter, a process called coagulation or clotting. The clotting time and blood clotting ability can be measured with a coagulometer.
The term "coagulation tests" describes the various methods used to determine how well and how long blood clots. This method is useful for assessing the potential for thrombosis or heavy bleeding. Hemophilia, thrombophilia, and liver disorders are among the many possible causes of coagulation difficulties. Thrombin time, platelet count, fibrinogen level, and whole blood count are among the most typical coagulation tests.
The global increase in the incidence of cardiovascular diseases and blood disorders is a key component propelling the coagulation testing market forward. The market is being propelled by rising public awareness of these conditions, which is leading to an improvement in the diagnostic rate and preventative care management. Additionally, the market is being powered by an increase in government funds and investments for the procurement and installation of these medical devices into public healthcare facilities. The market is further impacted by the increasing number of persons with hemophilia and the expanding base of medical device installations. The growth of healthcare facilities, an aging population, an increase in the number of people requiring complex diagnostic tests, and the prevalence of research and development all work to boost the coagulation testing market. Market participants can expect lucrative prospects during the forecast period due to rising reagent rental business and expanding economies.
Factors such as an aging population, an increase in the number of people hospitalized for blood disorders and cardiovascular diseases, a surge in the number of people needing coagulation tests at the point of care, a surge in the demand for disposable coagulation testing products, innovations like user-friendly devices, and the ease of access to these tests online are all expected to propel the coagulation testing market forward in the coming years. However, the market expansion throughout the forecast period is expected to be constrained by the high cost of the devices and tight regulatory restrictions.
Coagulation tests determine whether blood can clot and, if so, for how long. A doctor can use this test to gauge the patient's risk of serious bleeding or blood clots in the veins. The risk of thrombosis (blood vessel clots) and excessive bleeding can be better assessed with the use of tests. Complete blood count (CBC), fibrinogen level, Factor V assay, prothrombin time, platelet count, thrombin time, and bleeding time are some frequent types of coagulation tests.
The increasing number of chronic blood ailments is expected to drive the global market for coagulation testing to expand at a quick pace. Rising demand for highly trained hematology and coagulation laboratories is likely to boost the coagulation testing industry. Modern techniques like photoacoustic detection, electrochemical sensing, microfluidics, and fluorescence microscopy are utilized to fabricate point-of-care (POC) devices. The visual, mechanical, and electrochemical components of blood clotting are mostly measured by point-of-care (POC) devices. The coagulation testing market is expected to expand at a faster rate due to these technological improvements.
Using qualitative and quantitative data, the research paints a comprehensive picture of the market. The report summarizes and forecasts the worldwide coagulation testing market by segments. In addition, the report breaks down the market by region, offering projections for each of the five most important areas from 2020 to 2028: North America, Europe, Asia-Pacific (APAC), MEA, and South and Central America. Subsegmentation of the Coagulation Testing market is done based on nations and segments within each region. The research delves into the present trend and potential prospects in the region, as well as an analysis and prediction of 18 countries worldwide.
Report Coverage
Global Coagulation Testing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Coagulation Testing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Coagulation Testing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Coagulation Testing market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Coagulation Testing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Coagulation Testing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Abbott Laboratories, Alere Inc., Diagnostica Stago Sas, Medtronic plc, Helena Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Micropoint Biosciences
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Coagulation Testing market based on the below-mentioned segments:
Global Coagulation Testing Market, By Product
Instruments
Consumables
Global Coagulation Testing market, By Application
Prothrombin Time
Activated Partial Thromboplastin Time
Thrombin Time
Activated Clotting Time
Global Coagulation Testing Market, By End User
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others
Global Coagulation Testing market, Regional Analysis
The term "coagulation tests" describes the various methods used to determine how well and how long blood clots. This method is useful for assessing the potential for thrombosis or heavy bleeding. Hemophilia, thrombophilia, and liver disorders are among the many possible causes of coagulation difficulties. Thrombin time, platelet count, fibrinogen level, and whole blood count are among the most typical coagulation tests.
The global increase in the incidence of cardiovascular diseases and blood disorders is a key component propelling the coagulation testing market forward. The market is being propelled by rising public awareness of these conditions, which is leading to an improvement in the diagnostic rate and preventative care management. Additionally, the market is being powered by an increase in government funds and investments for the procurement and installation of these medical devices into public healthcare facilities. The market is further impacted by the increasing number of persons with hemophilia and the expanding base of medical device installations. The growth of healthcare facilities, an aging population, an increase in the number of people requiring complex diagnostic tests, and the prevalence of research and development all work to boost the coagulation testing market. Market participants can expect lucrative prospects during the forecast period due to rising reagent rental business and expanding economies.
Factors such as an aging population, an increase in the number of people hospitalized for blood disorders and cardiovascular diseases, a surge in the number of people needing coagulation tests at the point of care, a surge in the demand for disposable coagulation testing products, innovations like user-friendly devices, and the ease of access to these tests online are all expected to propel the coagulation testing market forward in the coming years. However, the market expansion throughout the forecast period is expected to be constrained by the high cost of the devices and tight regulatory restrictions.
Coagulation tests determine whether blood can clot and, if so, for how long. A doctor can use this test to gauge the patient's risk of serious bleeding or blood clots in the veins. The risk of thrombosis (blood vessel clots) and excessive bleeding can be better assessed with the use of tests. Complete blood count (CBC), fibrinogen level, Factor V assay, prothrombin time, platelet count, thrombin time, and bleeding time are some frequent types of coagulation tests.
The increasing number of chronic blood ailments is expected to drive the global market for coagulation testing to expand at a quick pace. Rising demand for highly trained hematology and coagulation laboratories is likely to boost the coagulation testing industry. Modern techniques like photoacoustic detection, electrochemical sensing, microfluidics, and fluorescence microscopy are utilized to fabricate point-of-care (POC) devices. The visual, mechanical, and electrochemical components of blood clotting are mostly measured by point-of-care (POC) devices. The coagulation testing market is expected to expand at a faster rate due to these technological improvements.
Using qualitative and quantitative data, the research paints a comprehensive picture of the market. The report summarizes and forecasts the worldwide coagulation testing market by segments. In addition, the report breaks down the market by region, offering projections for each of the five most important areas from 2020 to 2028: North America, Europe, Asia-Pacific (APAC), MEA, and South and Central America. Subsegmentation of the Coagulation Testing market is done based on nations and segments within each region. The research delves into the present trend and potential prospects in the region, as well as an analysis and prediction of 18 countries worldwide.
Report Coverage
Global Coagulation Testing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Coagulation Testing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Coagulation Testing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Coagulation Testing market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Abbott Laboratories, Alere Inc., Diagnostica Stago Sas, Medtronic plc, Helena Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Micropoint Biosciences |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Coagulation Testing Market from 2021 to 2031.
- Market Forecast for Coagulation Testing Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Coagulation Testing competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Coagulation Testing
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Coagulation Testing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Coagulation Testing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Abbott Laboratories, Alere Inc., Diagnostica Stago Sas, Medtronic plc, Helena Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Micropoint Biosciences
Primary Target Market
- Market Players of Coagulation Testing
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Coagulation Testing market based on the below-mentioned segments:
Global Coagulation Testing Market, By Product
Instruments
Consumables
Global Coagulation Testing market, By Application
Prothrombin Time
Activated Partial Thromboplastin Time
Thrombin Time
Activated Clotting Time
Global Coagulation Testing Market, By End User
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others
Global Coagulation Testing market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive coagulation testing market market research and competitor analysis for your business to help you develop more profound insights into the coagulation testing market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the coagulation testing market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.